Abstract
Bone health was assessed for inhabitants of an area affected by the Fukushima nuclear plant incident. Osteoporotic patients, who had been treated with active vitamin D3 and/or bisphosphonate at Soma Central Hospital before the Fukushima incident, were enrolled. Changes in bone turnover markers and bone mineral density were retrospectively analyzed. Serum levels of a bone resorption marker, serum type I collagen cross-linked N-telopeptide were decreased in all the treated groups, whereas those of a bone formation marker, bone-specific alkaline phosphatase, were increased. Accordingly, bone mineral density, estimated by dual-energy X-ray absorptiometry, was increased in the lumbar spine of all groups, but bone mass increase in the proximal femur was detected only in the group treated with the two agents in combination. From the degree of these parameter changes, the antiosteoporotic treatments looked effective and were equivalent to the expected potency of past observations. At this stage, the present study implies that the Fukushima nuclear incident did not bring an acute risk to bone health in the affected areas.
References
Rodan GA, Martin TJ (2000) Therapeutic approaches to bone diseases. Science 289:1508–1514
Harada S, Rodan GA (2003) Control of osteoblast function and regulation of bone mass. Nature (Lond) 423:349–355
Rosen CJ (2005) Clinical practice. Postmenopausal osteoporosis. N Engl J Med 353:595–603
Watanabe Y, Ohshima H, Mizuno K, Sekiguchi C, Fukunaga M, Kohri K, Rittweger J, Felsenberg D, Matsumoto T, Nakamura T (2004) Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res 19:1771–1778
Fukumoto S, Martin TJ (2009) Bone as an endocrine organ. Trends Endocrinol Metab 20:230–236
Karsenty G, Kronenberg HM, Settembre C (2009) Genetic control of bone formation. Annu Rev Cell Dev Biol 25:629–648
Takayanagi H (2007) Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat Rev Immunol 7:292–304
Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638–649
Ogawa S, Ishiki M, Nako K, Okamura M, Senda M, Sakamoto T, Ito S (2012) Effects of the Great East Japan Earthquake and huge tsunami on glycaemic control and blood pressure in patients with diabetes mellitus. BMJ Open 2(2):e000830
Aoki T, Fukumoto Y, Yasuda S, Sakata Y, Ito K, Takahashi J, Miyata S, Tsuji I, Shimokawa H (2012) The Great East Japan Earthquake Disaster and cardiovascular diseases. Eur Heart J 33:2796–2803
Harasawa K, Tanimoto T, Kami M, Oikawa T, Kanazawa Y, Komatsu H (2012) Health problems in the temporary housing in Fukushima. Lancet 379:2240–2241
Weinstein RS (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365:62–70
Pearce G, Tabensky DA, Delmas PD, Baker HW, Seeman E (1998) Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83:801–806
Hayano RS, Tsubokura M, Miyazaki M, Satou H, Sato K, Masaki S, Sakuma Y (2013) Internal radio-cesium contamination of adults and children in Fukushima 7 to 20 months after the Fukushima NPP accident as measured by extensive whole-body-counter surveys. Proc Jpn Acad Ser B Phys Biol Sci 89:157–163
Tsubokura M, Takita M, Matsumura T, Hara K, Tanimoto T, Kobayashi K, Hamaki T, Oiso G, Kami M, Okawada T, Tachiya H (2013) Changes in metabolic profiles after the Great East Japan Earthquake: a retrospective observational study. BMC Public Health 13:267
Plum LA, Deluca HF (2010) Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9:941–955
Liberman UA, Weiss SR, Bröll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Fravus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. N Engl J Med 333:1437–1443
Harris ST, Watts NB, Genant HK, McKeever CD, Hangartner T, Keller M, Chesnut CH 3rd, Brown J, Eriksen EF, Hoseyni MS, Axelrod DW, Miller PD (1999) Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group. JAMA 282:1344–1352
Barik J, Marti F, Morel C, Fernandez SP, Lanteri C, Godeheu G, Tassin JP, Mombereau C, Faure P, Tronche F (2013) Chronic stress triggers social aversion via glucocorticoid receptor in dopaminoceptive neurons. Science 339:332–335
Niwa M, Jaaro-Peled H, Tankou S, Seshadri S, Hikida T, Matsumoto Y, Cascella NH, Kano S, Ozaki N, Nabeshima T, Sawa A (2013) Adolescent stress-induced epigenetic control of dopaminergic neurons via glucocorticoids. Science 339:335–339
Tolstykh EI, Shagina NB, Degteva MO, Anspaugh LR, Napier BA (2011) Does the cortical bone resorption rate change due to 90Sr-radiation exposure? Analysis from Techa Riverside residents. Radiat Environ Biophys 50:417–430
Akleyev AV, Dimov GP, Varfolomeyeva TA (2010) Late effects in hemopoiesis and bone tissue among people with incorporated osteotropic isotope 90Sr. Health Phys 98:819–824
Wertelecki M (2010) Malformation in a Chernobyl-impacted region. Pediatrics 125:e836–e843
Marx RE, Johnson RP (1987) Studies in the radiobiology of osteoradionecrosis and their clinical significance. Oral Surg Oral Med Oral Pathol 64:379–390
Xu W, Xu L, Chen M, Mao YT, Xei ZG, Wu SL, Dong QR (2012) The effects of low dose X-irradiation on osteoblastic MC3T3-E1 cells in vitro. BMC Musculoskel Disord 13:94
Park SS, Kim KA, Lee SY, Kim SS, Jeon YM, Lee JC (2012) X-ray radiation at low doses stimulates differentiation and mineralization of mouse calvarial osteoblasts. BMB Rep 45:571–576
Jia D, Gaddy D, Suva LJ, Corry PM (2011) Rapid loss of bone mass and strength in mice after abdominal irradiation. Radiat Res 176:624–635
Bonewald LF (2007) Osteocytes as dynamic multifunctional cells. Ann N Y Acad Sci 1116:281–290
Bonewald LF (2011) The amazing osteocyte. J Bone Miner Res 26:229–238
Tsubokura M, Gilmour S, Takahashi K, Oikawa T, Kanazawa Y (2012) Internal radiation exposure after the Fukushima nuclear power plant disaster. JAMA 308:669–670
Conflict of interest
The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Ishii, T., Ito, K., Kato, S. et al. A report from Fukushima: an assessment of bone health in an area affected by the Fukushima nuclear plant incident. J Bone Miner Metab 31, 613–617 (2013). https://doi.org/10.1007/s00774-013-0482-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00774-013-0482-5